Companies
ABN AMRO Capital Life Science, Narden,
Netherlands
Amgen, Thousand Oaks, CA
Bank of America Securities, New York, NY
BankInvest BioVenture, Copenhagen, Denmark
Baxter Healthcare, Irvine, CA
Becton Dickinson & Company, Research
Triangle Park, NC
Beyerishe Vereinsbank, Munich, Germany
Biopra International, Villa Park, CA
Cheng Xin Venture Capital Corporation, Taipei,
Taiwan
Cowen & Company, New York, NY
Dresdner Kleinwort Benson LLP, London, England
DYAX Corporation, Cambridge, MA
Eli Lilly & Company, Indianapolis, IN
Exploit Technologies Pte Lte, Singapore
Garvan Institute, Sydney, Australia
Genentech, South San Francisco, CA
Genzyme Corporation, Cambridge, MA
Glaxo Wellcome, Research Triangle Park,
NC
Harkins Cunningham, Philadelphia, PA
Hewlett-Packard, Andover, MA
Hwaxing Capital Corporation, Taipei, Taiwan
Investor International, New York, NY
Irell & Manella, Los Angeles, CA
J.P. Morgan, New York, NY
Life Sciences Partners, Amsterdam, Netherlands
Microsoft, Redmond, WA
Mintz Levin, Boston, MA
Morgan Stanley, San Francisco, CA
Orbimed Advisors, New York, NY
Paperboy Ventures, Washington, DC
Punk, Ziegel & Knoell LLP, New York,
NY
Ribozyme Pharmaceuticals, Boulder, CO
Roche Bioscience, Palo Alto, CA
Skadden, Arps, Slate, Meagher & Flom
LLP, San Francisco, CA
Sumitomo Corporation of America, New York,
NY
Transgene Corporation, Strasbourg, France
Vector Fund Management, Deerfield, IL
Womble, Carlyle, Sandridge & Rice LLP,
Raleigh, NC
|